On February 27, 2012, the Alliance for Safe Biologic Medicines and Bloomberg Government hosted a lunch time Biosimilars Forum on Capitol Hill to discuss the FDA’s draft guidance documents on biosimilar product development.

Panelists included:

  • Brian Rye, Health-Care Financial Analyst with Bloomberg Government (moderator)
  • Dr. Richard Dolinar, Chairman of the Alliance for Safe Biologic Medicines
  • Dr. David Charles, Chief Medical Officer, Vanderbilt Neuroscience Institute, Chairman of the Alliance for Patient Access, and ASBM member partner
  • Seth Ginsberg, Co-Founder and President of the Global Health Living Foundation, and ASBM member partner
  • Andrew Spiegel, CEO and co-founder of the Colon Cancer Alliance, and ASBM member partner
  • Martha Raymond, Patient Advocate, Colon Cancer Alliance
  • Jeffrey P. Kushan, Partner, Sidley-Austin LL


For audio of the event see below:

  • Brian Rye
    1. Introduction of Ginsberg, Spiegel, & Raymond Audio
    2. Introduction of Richard Dolinar, & David Charles Audio
  • Dr. Richard Dolinar Audio
  • Dr. David Charles Audio
  • Seth Ginsberg Audio
  • Andrew Speigel Audio
  • Martha Raymond Audio
  • Jeffrey P. Kushan Audio